NCT02852044

Brief Summary

For decades, it has been known that post-meal blood glucose concentrations were associated with the risk of T2D, which was reflected in early diagnostic guidelines. The oral glucose tolerance test (OGTT) has been used since at least 1923 and has remained the most common test for assessing glucose tolerance. Arterial blood (or arterialised blood using heated hand technique) is most appropriate for determining glucose tolerance and insulin sensitivity since this best represents the concentrations of metabolites and hormones that peripheral tissues are exposed to. It is essential to investigate whether venous blood (sometimes used during an OGTT) is representative of arterialised blood during an OGTT, and under different metabolic conditions. The investigators want to understand whether OGTT-derived insulin sensitivity indices differ from venous and arterialised blood; and 2) investigate whether metabolic status (i.e. rest vs lower-limb exercise) influences the difference between forearm venous and arterialised concentrations of glucose and insulin during an OGTT.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2015

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2015

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2016

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 28, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 2, 2016

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
Last Updated

October 25, 2016

Status Verified

October 1, 2016

Enrollment Period

5 months

First QC Date

July 28, 2016

Last Update Submit

October 24, 2016

Conditions

Outcome Measures

Primary Outcomes (2)

  • Postprandial plasma glucose concentrations (area under the concentration-time curve)

    120 mins

  • OGTT-derived insulin sensitivity

    120 mins

Secondary Outcomes (8)

  • Fasting plasma glucose concentrations

    5 mins

  • Fasting plasma insulin concentrations

    5 mins

  • Fasting plasma lactate concentrations

    5 mins

  • Fasting plasma triglyceride concentrations

    5 mins

  • Postprandial plasma lactate concentrations (area under the concentration-time curve)

    120 mins

  • +3 more secondary outcomes

Study Arms (2)

Rest

ACTIVE COMPARATOR

Remain rested prior to the oral glucose tolerance test

Behavioral: RestOther: Dorsal Hand Vein Cannulation (heated hand technique)Other: Venous Cannulation

Exercise

EXPERIMENTAL

Complete exercise prior to the oral glucose tolerance test

Behavioral: ExerciseOther: Dorsal Hand Vein Cannulation (heated hand technique)Other: Venous Cannulation

Interventions

RestBEHAVIORAL

Allowed to watch television or read for one hour prior to oral glucose tolerance test

Rest
ExerciseBEHAVIORAL

One hour of cycling at 50% of maximal power output

Exercise
ExerciseRest

Eligibility Criteria

Age18 Years - 49 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Aged 18-49 years
  • Able and willing to safely comply with all study procedures
  • Able to provide written informed consent for participation

You may not qualify if:

  • Diagnosis of any bleeding disorder or taking medication which impacts blood coagulation
  • The presence of any contraindications to maximal exercise testing, as determined using a physical activity readiness questionnaire (PAR-Q).
  • Any diagnosis of metabolic disease (i.e. cardiovascular disease or type 2 diabetes).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department for Health, University of Bath

Bath, Bath, BA2 7AY, United Kingdom

Location

Related Publications (2)

  • Nauck MA, Liess H, Siegel EG, Niedmann PD, Creutzfeldt W. Critical evaluation of the 'heated-hand-technique' for obtaining 'arterialized' venous blood: incomplete arterialization and alterations in glucagon responses. Clin Physiol. 1992 Sep;12(5):537-52. doi: 10.1111/j.1475-097x.1992.tb00357.x.

    PMID: 1395446BACKGROUND
  • Liu D, Moberg E, Kollind M, Lins PE, Adamson U, Macdonald IA. Arterial, arterialized venous, venous and capillary blood glucose measurements in normal man during hyperinsulinaemic euglycaemia and hypoglycaemia. Diabetologia. 1992 Mar;35(3):287-90. doi: 10.1007/BF00400932.

    PMID: 1563586BACKGROUND

MeSH Terms

Conditions

HyperglycemiaInsulin Resistance

Interventions

RE1-silencing transcription factorExercise

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesHyperinsulinism

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

July 28, 2016

First Posted

August 2, 2016

Study Start

November 1, 2015

Primary Completion

April 1, 2016

Study Completion

September 1, 2016

Last Updated

October 25, 2016

Record last verified: 2016-10

Data Sharing

IPD Sharing
Will not share

Locations